A profound transformation is sweeping the fashion industry, driven not by a new designer or textile, but by a class of drugs: GLP-1 medications like Ozempic.
As their use surges globally, the physical effects of rapid, often dramatic weight loss are exposing fundamental flaws in how fashion approaches sizing, fit, and inventory planning. This trend is not merely about ordering more small sizes; it is forcing brands to confront a new reality of “size volatility,” where bodies fluctuate and fixed measurements are becoming obsolete.
Lexy Onofrio, chief marketing officer of Chico’s FAS, describes it as a new, open conversation.
“Women are coming in with this and talking about it,” she noted, referring to customers who have experienced significant weight loss from GLP-1s.
The impact is tangible across the industry. In its second-quarter earnings call in March, StitchFix CEO Matt Baer revealed a 75% surge in customer mentions of weight loss in styling notes over the last two years, a figure that has since grown another 20%. This data is echoed by a May report from Morning Consult, which identified GLP-1 users as a distinct consumer cohort who not only shop more often but spend more; 71 percent are shopping for apparel in a given month, with a growing share becoming heavy buyers.
However, the challenge is far more complex than simply catering to thinner bodies. The weight loss induced by GLP-1 drugs often results in specific physiological changes, such as a loss of tissue density and elasticity. This creates new fit issues, as described by Holly Ann Burningham, a design veteran at the intimates brand Soma.
“When you’ve lost weight, you get that kind of hollow spot at the top of your cup — a lot of women experience that gaping at the neckline of their bras,” Burningham explained.
To address this, Soma is relaunching a reimagined “top fill bra,” an innovation originally popular with new mothers, betting it will resonate with the roughly one in eight Americans who have used GLP-1 medications. Retail experts emphasize that brands must move beyond a static view of size.
“The best-positioned brands are increasingly designing for body fluctuation and ‘size volatility,’ rather than treating sizing as fixed and static,” the analysis notes.
Those that can offer flexibility, speed, and personalized fit solutions are poised to gain a significant advantage as GLP-1 users emerge as a powerful new force in the market.
Leave a Reply